Tumor Cell–Derived Angiopoietin-2 Promotes Metastasis in Melanoma
- 15 June 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (12), 2586-2598
- https://doi.org/10.1158/0008-5472.can-19-2660
Abstract
The angiopoietin (Angpt)–TIE signaling pathway controls vascular maturation and maintains the quiescent phenotype of resting vasculature. The contextual agonistic and antagonistic Tie2 ligand ANGPT2 is believed to be exclusively produced by endothelial cells, disrupting constitutive ANGPT1–TIE2 signaling to destabilize the microvasculature during pathologic disorders like inflammation and cancer. However, scattered reports have also portrayed tumor cells as a source of ANGPT2. Employing ISH-based detection of ANGPT2, we found strong tumor cell expression of ANGPT2 in a subset of patients with melanoma. Comparative analysis of biopsies revealed a higher fraction of ANGPT2-expressing tumor cells in metastatic versus primary sites. Tumor cell–expressed Angpt2 was dispensable for primary tumor growth, yet in-depth analysis of primary tumors revealed enhanced intratumoral necrosis upon silencing of tumor cell Angpt2 expression in the absence of significant immune and vascular alterations. Global transcriptional profiling of Angpt2-deficient tumor cells identified perturbations in redox homeostasis and an increased response to cellular oxidative stress. Ultrastructural analyses illustrated a significant increase of dysfunctional mitochondria in Angpt2-silenced tumor cells, thereby resulting in enhanced reactive oxygen species (ROS) production and downstream MAPK stress signaling. Functionally, enhanced ROS in Angpt2-silenced tumor cells reduced colonization potential in vitro and in vivo. Taken together, these findings uncover the hitherto unappreciated role of tumor cell–expressed ANGPT2 as an autocrine-positive regulator of metastatic colonization and validate ANGPT2 as a therapeutic target for a well-defined subset of patients with melanoma. Significance: This study reveals that tumor cells can be a source of ANGPT2 in the tumor microenvironment and that tumor cell-derived ANGPT2 augments metastatic colonization by protecting tumor cells from oxidative stress.Keywords
Other Versions
Funding Information
- Deutsche Forschungsgemeinschaft (248813719)
- DFG (259332240)
- DFG (CRC-TR209)
- European Research Council (787181)
This publication has 36 references indexed in Scilit:
- Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activationCancer Letters, 2013
- Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancerThe FASEB Journal, 2011
- The Regulation and Physiology of Mitochondrial Proton LeakPhysiology, 2011
- Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGFLeukemia Research, 2010
- Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant MelanomaClinical Cancer Research, 2009
- Host-Derived Angiopoietin-2 Affects Early Stages of Tumor Development and Vessel Maturation but Is Dispensable for Later Stages of Tumor GrowthCancer Research, 2009
- Angiopoietin-2 Stimulates Breast Cancer Metastasis through the α5β1 Integrin-Mediated PathwayCancer Research, 2007
- Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2Cancer Cell, 2004
- The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodiesPublished by American Society of Hematology ,2004
- Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survivalInternational Journal of Cancer, 2002